A Direct Comparison of the Performance of HemoCue Plasma/Low HB Analyzer versus Optical Spectroscopy for Quality Control Measurements of Free Hemoglobin in Blood Components
While obtained results were highly similar using both devices when assessing fHb in EC, HemoCue showed a consistent overestimation of fHb in FP samples compared to spectrophotometry. HemoCue demonstrated acceptable intraday and interday precision across concentration ranges and offers operational advantages, including faster turnaround times. Altogether in quality control analyses, HemoCue turned out to be a valuable tool for fHb measurements in EC with some limitations for FP.
Authors
- Lisa Seekircher (ORCID: https://orcid.org/0000-0003-0260-3262)
- Peter Willeit (ORCID: https://orcid.org/0000-0002-1866-7159)
- Lena Tschiderer (ORCID: https://orcid.org/0000-0001-7988-853X)
- Marco Amato (ORCID: https://orcid.org/0009-0002-4296-9760)
- Anita Siller (ORCID: https://orcid.org/0009-0003-7860-7144)
- Daniela Schmidt
- Harald Schennach (ORCID: https://orcid.org/0009-0005-8536-8780)
Institutions
- Innsbruck Medical University (AT)
- Universität Innsbruck (AT)
- University of Cambridge (GB)
- Tirol Kliniken (AT)
Publication Details
- Journal
- Transfusion Medicine and Hemotherapy
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1159/000548744
- Primary Topic
- Non-Invasive Vital Sign Monitoring
- Type
- article
- Field-Weighted Citation Impact
- 0.00